Sorafenib-RT Treatment for Liver Metastasis (SLIM)
NCT00892424
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Liver Metastasis
Cancer
Interventions
DRUG:
Sorafenib
Sponsor
University Health Network, Toronto